意大利角质细胞癌的发病率:基于黑色素瘤数据的间接估计
European journal of dermatology : EJD
|August 18, 2023
概括
细胞癌 (KC) 的发病率,包括基底细胞癌 (BCC) 和状细胞癌 (SCC),在意大利似乎被低估了. 组织病理学数据表明,与皮肤科医生自我报告相比,KC发生率较低.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 在全球范围内,角质细胞癌 (KC) 的发病率正在上升,但数据仍然不完整.
- 准确的KC发生数据对于公共卫生和资源分配至关重要.
研究的目的:
- 为了确定细胞癌 (KC) 与黑色素瘤的比率,用于间接的KC发病率估计.
- 为了将组织病理学数据与皮肤科医生自我报告的KC发生率进行比较.
主要方法:
- 意大利皮肤科医生的雪球采样,以收集KC/黑色素瘤比率.
- 排除黑色素瘤和非黑色素瘤部门的专家.
- 将收集的比率应用于来自意大利国家癌症登记网络的黑色素瘤发病率数据.
主要成果:
- 基础细胞癌 (BCC) /黑色素瘤的比率为4.4,状细胞癌 (SCC) /黑色素瘤的比率为1.7.
- 这些比率明显低于皮肤科医生自我报告的比率.
- 意大利的BCC/SCC比率显示区域差异,总值为2.8,与2.6的组织病理比率密切一致.
结论:
- 组织病理学数据表明,意大利的BCC和SCC发生率被严重低估.
- 报告和实际KC发病率之间的差异凸显了需要改进数据收集方法的需要.
相关概念视频
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
Kaplan-Meier Approach
179
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
179
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)

